Filing Details

Accession Number:
0001209191-15-025198
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-11 16:39:06
Reporting Period:
2015-03-09
Filing Date:
2015-03-11
Accepted Time:
2015-03-11 16:39:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1593034 Endo International Plc ENDP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1554635 Camille Farhat C/O American Medical Systems
10700 Bren Road West
Minnetonka MN 55343
President, Ams, Inc. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-03-09 35,589 $32.27 44,239 No 4 M Direct
Ordinary Shares Acquisiton 2015-03-09 4,849 $30.80 49,088 No 4 M Direct
Ordinary Shares Disposition 2015-03-09 40,438 $87.02 8,650 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares 2010 Stock Incentive Plan Stock Options (NQ) Disposition 2015-03-09 35,589 $0.00 35,589 $32.27
Ordinary Shares Assumed Stock Incentive Plan Stock Options (NQ) Disposition 2015-03-09 4,849 $0.00 4,849 $30.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
35,588 2022-09-05 No 4 M Direct
4,848 2020-02-27 No 4 M Direct
Footnotes
  1. This represents the average price at which Mr. Farhat's ordinary shares were sold on March 9, 2015.
  2. Mr. Farhat's stock options that were granted under the 2010 Stock Incentive Plan on September 5, 2012 were generally exercisable 25% per year on each of September 5, 2013, September 5, 2014, September 5, 2015, and September 5, 2016.
  3. These securities were granted to Mr. Farhat in consideration of his services as the President of American Medical Systems, a subsidiary of Endo International plc.
  4. Mr. Farhat's stock options that were granted under the Assumed Stock Incentive Plan on February 27, 2013 were generally exercisable 25% per year on each of February 27, 2014, February 27, 2015, February 27, 2016, and February 27, 2017.